Groombridge Wu Baughman Stone LLP

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases58

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechComp. Arch. and SoftwareTransport., E-Comm.

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [316] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-3)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [314] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-2)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [312] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibit 1)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [310] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-5)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [308] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-2)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [306] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-3)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [304] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibits 1-10)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [302] Declaration,, by BioNTech Manufacturing GmbH, BioNTech SE. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4-21)(Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [301] Statement, by BioNTech Manufacturing GmbH, BioNTech SE. (Tigan, Jeremy) (Entered: 01/16/2025)
01/16/25	Alnylam Pharmaceuticals Inc v. Pfizer Inc 1:22-CV-00336 ( D. DE )	REDACTED VERSION of [300] Opening Brief in Support, by BioNTech Manufacturing GmbH, BioNTech SE. (Tigan, Jeremy) (Entered: 01/16/2025)